sar445419
Cell therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 16, 2023 (NCT05712278)
Timeline
Indications
Mechanism of action
- Natural killer cellImmunity, passive
Natural killer cell immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05726682 | Phase 2 | Feb 23, 2024 | Sanofi |
| NCT05712278 | Phase 1 | Jun 16, 2023 | Sanofi |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sanofi | For profit | 2 | 2 | 2 | 2023 |
1 organizations
Page 1 / 1